FOLH1 and prostate carcinoma: In summary, this case illustrates the potential pitfalls in PSMA-ligand PET-imaging given that PSMA-expression is also present in non-prostate cancer lesions and highlights the necessity of thorough analysis of the accompanying cross-sectional imaging modality.